SCM
RVMD icon

Soleus Capital Management’s Revolution Medicines RVMD Stock Holding History

Soleus Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$368K – 103
2025
Q2 		$368K Sell
10,000
-74,784
-88% -$2.87M 0.02% 91
2025
Q1 		$3M Sell
84,784
-116,300
-58% -$4.72M 0.22% 57
2024
Q4 		$8.8M Sell
201,084
-503,500
-71% -$25.4M 0.55% 43
2024
Q3 		$32M Sell
704,584
-151,594
-18% -$6.6M 2.47% 13
2024
Q2 		$33.2M Buy
856,178
+127,478
+17% +$4.76M 2.93% 7
2024
Q1 		$23.5M Buy
728,700
+476,700
+189% +$14.1M 1.74% 15
2023
Q4 		$7.23M Buy
+252,000
New +$6.06M 0.8% 39
2021
Q3 		– Sell
-125,700
Closed -$3.99M – 82
2021
Q2 		$3.99M Buy
125,700
+68,500
+120% +$2.39M 0.61% 34
2021
Q1 		$2.62M Buy
+57,200
New +$2.57M 0.47% 43

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return